Mats Walder

Mats Walder

UNVERIFIED PROFILE

Are you Mats Walder?   Register this Author

Register author
Mats Walder

Mats Walder

Publications by authors named "Mats Walder"

Are you Mats Walder?   Register this Author

14Publications

-Reads

Risk factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli in a county of Southern Sweden.

Infect Drug Resist 2013 19;6:93-7. Epub 2013 Sep 19.

Infectious Diseases Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden.

View Article
October 2013

Prevalence of extended-spectrum beta-lactamase-producing bacteria in food.

Infect Drug Resist 2012 16;5:143-7. Epub 2012 Oct 16.

Infectious Diseases Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden.

View Article
October 2012

Duration of colonization with extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea.

Scand J Infect Dis 2012 Aug 31;44(8):573-7. Epub 2012 Jan 31.

Infectious Diseases Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden.

View Article
August 2012

Development of a real-time SYBRGreen PCR assay for rapid detection of acquired AmpC in Enterobacteriaceae.

J Microbiol Methods 2010 Sep 26;82(3):229-33. Epub 2010 Jun 26.

Swedish Institute for Infectious Disease Control, Stockholm, Sweden.

View Article
September 2010

Bacterial aetiology in ventilator-associated pneumonia at a Swedish university hospital.

Scand J Infect Dis 2010 Jul;42(6-7):469-74

Department of Clinical Sciences, Malmö, Lund University, Sweden.

View Article
July 2010

Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea.

Scand J Infect Dis 2010 Apr;42(4):275-80

Department of Clinical Sciences, Lund University, Malmö, Swden.

View Article
April 2010

Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion.

Antimicrob Agents Chemother 2010 Jan 2;54(1):346-52. Epub 2009 Nov 2.

Reference Centre for Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospital of North Norway, N-9038 Tromsø, Norway.

View Article
January 2010

Antimicrobial activity of tigecycline and comparative agents against clinical isolates of staphylococci and enterococci from ICUs and general hospital wards at three Swedish university hospitals.

Scand J Infect Dis 2009 ;41(3):171-81

Clinical Microbiology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linkoping University, Linkoping, Sweden.

View Article
April 2009

Pharmacodynamic studies of vancomycin, metronidazole and fusidic acid against Clostridium difficile.

Chemotherapy 2007 25;53(4):267-74. Epub 2007 Jun 25.

Infectious Diseases Research Unit, Department of Clinical Sciences, Malmö, Sweden.

View Article
September 2007

The throat: an important site for MRSA colonization.

Scand J Infect Dis 2006 ;38(10):888-93

Regional Centre for Communicable Disease Control, Skåne County, Lund University Hospital, Lund, Sweden.

View Article
December 2006

Epidemiological MIC cut-off values for tigecycline calculated from Etest MIC values using normalized resistance interpretation.

J Antimicrob Chemother 2006 Mar 12;57(3):498-505. Epub 2006 Jan 12.

Clinical Microbiology--MTC, Karolinska Institute, Karolinska Hospital L2:02, 17176 Stockholm, Sweden.

View Article
March 2006

Activity of three disinfectants and acidified nitrite against Clostridium difficile spores.

Infect Control Hosp Epidemiol 2003 Oct;24(10):765-8

Department of Infectious Diseases, Lund University, Malmö University Hospital, Malmö, Sweden.

View Article
October 2003